Abstract

The mechanistic target of rapamycin (mTOR) signaling pathway is highly conserved from yeast to humans. It senses various environmental cues to regulate cellular growth and homeostasis. Deregulation of the pathway has been implicated in many pathological conditions including cancer. Phosphorylation cascades through the pathway have been extensively studied but not much is known about the regulation of gene expression of the pathway components. Here, we report that the mRNA level of eukaryotic translation initiation factor (eIF) subunit 4E-binding protein (4E-BP) gene, one of the key mTOR signaling components, is regulated by the highly conserved Ccr4-Not complex. RNAi knockdown of Not1, a putative scaffold protein of this protein complex, increases the mRNA level of 4E-BP in Drosophila Kc cells. Examination of the gene expression mechanism using reporter swap constructs reveals that Not1 depletion increases reporter mRNAs with the 3’UTR of 4E-BP gene, but decreases the ones with the 4E-BP promoter region, suggesting that Ccr4-Not complex regulates both degradation and transcription of 4E-BP mRNA. These results indicate that the Ccr4-Not complex controls expression of a single gene at multiple levels and adjusts the magnitude of the total effect. Thus, our study reveals a novel regulatory mechanism of a key component of the mTOR signaling pathway at the level of gene expression.

Highlights

  • The mechanistic target of rapamycin signaling is involved in the regulation of a broad range of major cellular functions

  • We conclude that the Ccr4-Not complex represses 4E-binding protein (4E-BP) phosphorylation upon insulin stimulation in Kc cells

  • We show that the Ccr4-Not complex is involved in controlling the mRNA level of 4E-BP, a critical component of the mechanistic target of rapamycin (mTOR) signaling cascade

Read more

Summary

Introduction

The mechanistic target of rapamycin (mTOR) signaling is involved in the regulation of a broad range of major cellular functions. The GTP-bound Rheb activates the key regulatory kinase TOR complex 1 (TORC1) that phosphorylates the translational repressor 4E-BP (eukaryotic translation initiation factor (eIF) subunit 4E-binding protein) and up-regulates protein synthesis [4]. It is, conceivable that the magnitude of the signaling outputs is affected by the expression levels of the pathway components. The regulatory mechanisms by which the expression levels of these components are determined are still poorly understood

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call